Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 12,877 |
| Other current assets | 762 |
| TOTAL | $13,639 |
| Non-Current Assets | |
| PPE Net | 152 |
| Other Non-Current Assets | 314 |
| TOTAL | $466 |
| Total Assets | $14,104 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 3,613 |
| Accrued Expenses | 3,713 |
| TOTAL | $7,326 |
| Non-Current Liabilities | |
| Long Term Debt | 1,425 |
| Other Non-Current Liabilities | 2 |
| TOTAL | $1,441 |
| Total Liabilities | $8,767 |
| Shareholders' Equity | |
| Common Shares | 1 |
| Retained earnings | -67,914 |
| Other shareholders' equity | 72,062 |
| TOTAL | $5,337 |
| Total Liabilities And Equity | $14,104 |